CFTC tells court CME has no standing to challenge perps policy

The US Commodity Futures Trading Commission filed its reply brief on Friday October 16, 2026 in CME Group v. Selig, pushing back on CME's challenge to the agency's May 2026 policy opening the door to perpetual futures in the United States. The CFTC argues CME has not shown an injury concrete enough to establish Article III standing — and that CME's crypto futures volumes have risen, not fallen, since the policy change. CoinDesk reports the brief turns on standing, not on the merits of CME's "perps are swaps" theory.

What the brief says

The CFTC's position, as filed in the US District Court for the District of Columbia (Judge Colleen Kollar-Kotelly presiding), rests on Federal Rule of Civil Procedure 12(b)(1) — lack of jurisdiction — and failure to state a claim. Quoted language from the filing, via CoinDesk: "Allegations of increased competition, without any plausible inference of an imminent financial injury," do not establish standing.

Two factual anchors in the government's argument:

• CME is not barred from listing the same contracts the agency has now cleared for other venues; nothing stops the exchange from offering perps itself.
• CME's crypto futures volume has grown since the May 2026 policy was published in the Federal Register on June 3, 2026, which the agency reads as evidence that no imminent harm has materialized.

The Block noted in September that this is the second swing — the CFTC first moved to dismiss on September 2, 2026, calling the suit "much ado about nothing." Friday's brief answers CME's October 2 opposition. The CFTC and Chairman Michael S. Selig have also requested oral argument; the docket shows no hearing scheduled as of Thursday.

The policy being contested

The CFTC's May 2026 announcement said the agency would regulate perpetual futures as futures, case by case, rather than treat them as swaps requiring the Dodd-Frank clearing-and-reporting regime. The first product approved under that framing was a bitcoin perpetual future from Kalshi, which the agency cleared earlier this year.

CME's lawsuit, filed in late July 2026, argues the opposite reading: perps have no expiration date and therefore fall under the Commodity Exchange Act's definition of a swap. The classification matters because swaps come with mandatory clearing through a swap-execution facility and a different margin regime than futures.

Why the standing fight matters

A standing dismissal would not resolve the swap-versus-futures question on the merits. It would, however, leave the CFTC's May 2026 policy in place and unchallenged in federal court — and signal that other established exchanges challenging CFTC product approvals will face the same test: show concrete, imminent injury, not just the prospect of more competition.

For current and prospective US perp venues (Kalshi, Coinbase Derivatives, and any CFTC-registered DCM that files for a perp product), a dismissal removes near-term litigation risk around their contracts. For CME, losing on standing would push any future challenge back to the agency's rulemaking stage rather than the courthouse.

What to watch

1. The court's ruling on the motion to dismiss. No hearing is scheduled yet; Judge Kollar-Kotelly can rule on the papers.
2. New perp approvals from the CFTC while the suit is pending. Each new approval expands the record the agency can cite as evidence that CME has suffered no cognizable harm.
3. CME's own perp filing, if the exchange moves to list its own perpetual bitcoin futures. That would materially undercut the standing argument it is now making.

Context

This is the second large institutional challenge to CFTC crypto-derivatives rulemaking this cycle, following CME's earlier opposition to event-contract approvals. The pattern: a legacy derivatives exchange challenges a CFTC approval that benefits a newer venue, and the agency defends the approval on procedural rather than substantive grounds. The May 2026 perps policy and the Kalshi bitcoin perp are now the center of that fight.